PE-backed Arcadia Consumer Healthcare buys Kaopectate

Arcadia Consumer Healthcare Inc, which is backed by Avista Capital Partners, has acquired anti-diarrheal medicine Kaopectate from Sanofi.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this